CALA (Calithera Biosciences) EV-to-OCF: -0.00 (As of Aug. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Calithera Biosciences EV-to-OCF?

Calithera Biosciences CALA EV-to-OCF is -0.00 as of Aug. 02, 2026.

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Calithera Biosciences's Enterprise Value is $0.02 Mil. Calithera Biosciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2022 was $-43.61 Mil. Therefore, Calithera Biosciences's EV-to-OCF for today is -0.00.

The historical rank and industry rank for Calithera Biosciences's EV-to-OCF or its related term are showing as below:

CALA's EV-to-OCF is not ranked *
in the Diversified Financial Services industry.
Industry Median: -32.525
* Ranked among companies with meaningful EV-to-OCF only.

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-02), Calithera Biosciences's stock price is $0.0003. Calithera Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was $-8.650. Therefore, Calithera Biosciences's PE Ratio (TTM) for today is At Loss.

Calithera Biosciences  (OTCPK:CALA) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Calithera Biosciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0003/-8.650
=At Loss

Calithera Biosciences's share price for today is $0.0003.
Calithera Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.650.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Calithera Biosciences EV-to-OCF Related Terms

Calithera Biosciences EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Calithera Biosciences's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Calithera Biosciences EV-to-OCF Chart

Calithera Biosciences Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-OCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.30 -2.71 -2.83 0.08 -0.33

Calithera Biosciences Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EV-to-OCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CALA vs PPCB, QBIO, RGMP: EV-to-OCF Comparison

For the Shell Companies subindustry, Calithera Biosciences's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Calithera Biosciences EV-to-OCF vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Calithera Biosciences's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Calithera Biosciences's EV-to-OCF falls into.


Calithera Biosciences EV-to-OCF Calculation

Calithera Biosciences's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=0.024/-43.608
=-0.00

Calithera Biosciences's current Enterprise Value is $0.02 Mil.
Calithera Biosciences's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-43.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-OCF →
What does a EV-to-OCF of -0.00 mean?
Calithera Biosciences (CALA) has a EV-to-OCF of -0.00 as of Aug. 02, 2026.
Is Calithera Biosciences' EV-to-OCF too high?
Calithera Biosciences' current EV-to-OCF is -0.00.
How does Calithera Biosciences' EV-to-OCF compare to PPCB and QBIO?
Calithera Biosciences' EV-to-OCF of -0.00 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Diversified Financial Services company?
A good EV-to-OCF depends on the Diversified Financial Services industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Calithera Biosciences's current EV-to-OCF is -0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calithera Biosciences stock overvalued right now?
Calithera Biosciences (CALA) has a current EV-to-OCF of -0.00. The current EV-to-OCF is -0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Calithera Biosciences (CALA), the current EV-to-OCF is -0.00 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Calithera Biosciences Business Description

Address 343 Oyster Point Boulevard, Suite 200, South San Francisco, CA, USA, 94080
Calithera Biosciences Inc is a shell company.